Literature DB >> 4171891

Studies of nucleosides and nucleotides. XXXV. Purine cyclonucleosides. 5. Synthesis of purine cyclonucleoside having 8,2'-O-anhydro linkage and its cleavage reactions.

M Ikehara, H Tada, M Kaneko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4171891     DOI： 10.1016/s0040-4020(01)92646-8

Source DB:  PubMed          Journal:  Tetrahedron        ISSN： 0040-4020            Impact factor:   2.457


× No keyword cloud information.
  6 in total

1.  Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.

Authors:  Zhengxiang Zhu; John K Buolamwini
Journal:  Bioorg Med Chem       Date:  2008-01-30       Impact factor: 3.641

2.  Elongation of oligonucleotides in the 3'-direction with activated mononucleotides and their analogs using RNA ligase.

Authors:  E Ohtsuka; T Miyake; K Nagao; H Uemura; S Nishikawa; M Sugiura; M Ikehara
Journal:  Nucleic Acids Res       Date:  1980-02-11       Impact factor: 16.971

3.  A novel method for site specific introduction of single model oxidative DNA lesions into oligodeoxyribonucleotides.

Authors:  Z Hatahet; A A Purmal; S S Wallace
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

4.  5-Hydroxypyrimidine deoxynucleoside triphosphates are more efficiently incorporated into DNA by exonuclease-free Klenow fragment than 8-oxopurine deoxynucleoside triphosphates.

Authors:  A A Purmal; Y W Kow; S S Wallace
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

5.  Structure of oxidatively damaged nucleic acid adducts. 3. Tautomerism, ionization and protonation of 8-hydroxyadenosine studied by 15N NMR spectroscopy.

Authors:  B P Cho; F E Evans
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

6.  Total synthesis of a cyclic adenosine 5'-diphosphate ribose receptor agonist.

Authors:  Joanna M Swarbrick; Barry V L Potter
Journal:  J Org Chem       Date:  2012-01-31       Impact factor: 4.354
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.